David Parker is a General Partner at Ampersand Capital Partners, whose known portfolio counts 10 companies.
Is David Parker a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
Contacts
Affiliated funds' portfolios
General Partner at Ampersand Capital Partners, whose known portfolio counts 10 companies
- Vernal Biosciences
- Lexington Medical
- AnaBios
- Genezen
- Julius Clinical
- NanoImaging Services
- ProtaGene
- Purna Pharmaceuticals
- Sterling Medical Devices
- VIVEbiotech
Investor Profile
David Parker is listed against sectors Commerce, Hardware, Healthcare and SaaS, and focus areas Analytics, Biotech, CDMO and Design in the database.
Stage-wise, the deals at Ampersand Capital Partners cluster around Growth, Late-Stage and Seed rounds.
What the affiliated firm has backed is the closest available signal on whether David Parker is worth approaching.
Colleagues at Ampersand Capital Partners
Mario Reto
Principal
Boston, United States
Marina Pellón-Consunji
Partner
Amsterdam, Netherlands
Arya Mehrabanzad
Principal
Boston, United States
David Anderson
General Partner
Boston, United States
Eric Lev
General Partner
Boston, United States
Geoffrey Teillon
Partner
Boston, United States
Dana Niles
Chief Operating Officer
Boston, United States
Greg Magoon
Vice President
Holliston, United States
Melanie Fan
Partner
Boston, United States
Herb Hooper
Managing Partner
United States
Matthew Norton
General Partner
London, United Kingdom
Matthew Munfakh
Vice President
Boston, United States
Trevor Wahlbrink
General Partner
Boston, United States
Hidde Van Kerckhoven
Principal
Amsterdam, Netherlands
Max Keeley
Vice President
Amsterdam, Netherlands
David B. Patteson
Partner
United States
Frequently asked questions
Who is David Parker?
David Parker is a private equity investor based in Boston, Massachusetts, United States, listed as General Partner at Ampersand Capital Partners. The known portfolio of that firm counts 10 companies. That portfolio belongs to the firm, not to David Parker personally.
What does David Parker invest in?
Listed sectors include Commerce, Hardware, Healthcare and SaaS; listed focus areas include Analytics, Biotech, CDMO and Design. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does David Parker invest at?
Ampersand Capital Partners appears in Growth, Late-Stage and Seed rounds across its known deals, and David Parker is listed there as General Partner. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is David Parker listed at?
David Parker is listed as General Partner at Ampersand Capital Partners. 16 other people in the database share a firm with David Parker.
How do I contact David Parker?
An email address, a phone number and a LinkedIn page are on file for David Parker. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal